Clinical trial
Prevention of NMDA Antagonist-induced Psychosis and Memory Impairment in Children
NCT00205712 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of NMDA Antagonist-induced Psychosis and Memory Impairment in Children
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2003
- Completion date
- October 31, 2007
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.